Table 3 Cox regression analyses for factors predicting the progression of COVID-19
Covariate | HR (95% CI) | P |
|---|---|---|
Age, years | 1.038 (1.002–1.075) | 0.039 |
Hypertension | 2.295 (0.765–6.881) | 0.138 |
Fever | 1.278 (0.161–10.146) | 0.816 |
Cough | 3.336 (0.734–15.160) | 0.119 |
C-reactive protein, mg/L | 1.018 (1.005–1.030) | 0.004 |
Procalcitonin, ng/ml | 1.356 (1.092–1.684) | 0.006 |
T lymphocyte count, /μl | 0.999 (0.997–1.000) | 0.119 |
CD4+ lymphocyte count, /μl | 0.998 (0.995–1.001) | 0.148 |
CD8+ lymphocyte count, /μl | 0.998 (0.994–1.001) | 0.192 |
B lymphocyte count, /μl | 0.993 (0.984–1.002) | 0.133 |
NK lymphocyte count, /μl | 0.996 (0.989–1.002) | 0.205 |
IL-6, pg/ml | 1.021 (1.004–1.039) | 0.014 |
Lactate, mmol/L | 1.023 (1.004–1.043) | 0.018 |
NLR | 0.995 (0.904–1.095) | 0.921 |
CD4+/total T lymphocyte | 1.089 (0.041–29.038) | 0.959 |
CD8+/total T lymphocyte | 1.121 (0.019–67.083) | 0.956 |